The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys

The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys

Abstract The ongoing coronavirus disease 2019 (COVID-19) pandemic has caused disruption in all aspects of daily life, including the management and treatment of rare inherited metabolic disorders (IMDs). To perform a preliminary assessment of the incidence of COVID-19 in IMD patients and the impact o...

Full description

Bibliographic Details
Main Authors: C. Lampe, C. Dionisi-Vici, C. M. Bellettato, L. Paneghetti, C. van Lingen, S. Bond, C. Brown, A. Finglas, R. Francisco, S. Sestini, J. M. Heard, M. Scarpa, MetabERN collaboration group
Format: Article
Language:English
Published: BMC 2020-12-01
Series:Orphanet Journal of Rare Diseases
Subjects:
COVID-19
SARS-CoV-2
Coronavirus
Pandemic
Rare diseases
Inherited metabolic diseases
Online Access:https://doi.org/10.1186/s13023-020-01619-x

Internet

https://doi.org/10.1186/s13023-020-01619-x

Similar Items